Hauke Smidt is a Personal Professor at Wageningen University & Research, affiliated with the Molecular Ecology group within the Faculty of Veterinary Medicine and Animal Sciences. His research focuses on microbial ecology, particularly gut microbiota dynamics, antibiotic resistance, environmental microbiology, and the One Health framework. Smidt has supervised over 50 PhD students and contributed to 519 publications, including studies on microbiome resilience, fermented food impacts, and bioremediation strategies. Education and affiliations include leadership roles in projects addressing antimicrobial resistance, pig health, and drinking water microbiology. His work spans collaborations across Europe and Asia, with notable contributions to understanding microbial community responses to environmental stressors and dietary interventions. Smidt is actively involved in public outreach, as seen in media contributions discussing microbiome research and health benefits. Key projects include aquifer treatment for drinking water, microbiome simulation models, and combating plant pathogens. His awards and recognition are not explicitly listed, but his extensive publication record and project leadership highlight significant academic impact.
Leonie Bentsink is a Professor at the Laboratory of Plant Physiology , part of Wageningen University . Her research focuses on molecular mechanisms underlying seed dormancy, germination, and longevity in plants like Arabidopsis thaliana . She leads projects investigating translational regulation, seed microbiomes, and abiotic stress tolerance, supported by an NWO Vici grant (2018). Dr. Bentsink supervises multiple PhD candidates and has authored over 69 publications. Key contributions include discovering roles for genes like DOG1 and ANAC060 in dormancy regulation, and developing tools like the SeedTransNet translational network. Key Projects: Seed microbiome impacts on drought tolerance Seed germination cell communication mechanisms Spatial transcriptomics for abiotic stress resilience Datasets: 11 publicly available datasets on seed transcriptomes/metabolomes, including seed dormancy cycling and parental effect studies. Citations: Over 70 publications since 2000, with notable work on seed longevity and translational regulation.
Hans Bouwmeester is a Full Professor in Toxicology at Wageningen University & Research, specializing in chemical risk assessment, nanomaterial toxicity, and in vitro modeling. His work focuses on integrating artificial intelligence and physiologically based kinetic (PBK) models to predict toxic effects of contaminants like organophosphate pesticides, microplastics, and mycotoxins. He leads projects exploring the health impacts of foodborne contaminants in inflammatory bowel disease and developing animal-free testing methods. Key collaborations include EU initiatives like the ONTOX project and the GUTTEST program, which utilize advanced in vitro models such as gut-on-a-chip systems. Research interests span toxicokinetics, nanoplastics exposure, and the application of Bayesian networks for nanomaterial hazard ranking. His team addresses translational challenges in linking in vitro data to in vivo outcomes, with a focus on bile acid metabolism and cardiotoxicity prediction. Bouwmeester has supervised over 10 PhD candidates, including studies on microplastic hazard assessment, nanomaterial gastrointestinal fate, and AI-driven data extraction for risk assessment. Notable contributions include datasets on nanoplastics' protein corona effects and transcriptomic analyses of intestinal cell responses. His work is published in journals like Ecotoxicology and Environmental Safety , Toxicology , and Environmental Science & Technology , emphasizing open-access research and interdisciplinary approaches to chemical safety.
Judith Risse is a Postdoctoral Researcher in the Bioinformatics (BIF) department at Wageningen University & Research. Her work focuses on genomic and evolutionary studies, including phylogenomic analysis of plant development, insect adaptation, and microalgal biotechnology. She has contributed to projects involving genome sequencing, transcriptome analysis, and nanopore technologies. Education: Completed her PhD in Bioinformatics (2014) under Prof. Bisseling and Dr. Leunissen, focusing on text-mining for metabolic pathway reconstruction. Research Interests: Floral development in Asteraceae, evolutionary adaptation in insects (e.g., field crickets), and genomic mechanisms of stress tolerance in microalgae. Her work integrates computational biology with experimental genomics. Publications: Key contributions include studies on dandelion floral genetics (2023), great tit genome inversion analysis (2023), and microalgal thermotolerance (2022). She has also published on cricket genomics (2020) and viral photosynthesis interactions (2022). Projects: Led a PhD project on text-mining applications in metabolic pathway analysis. Currently involved in collaborative projects on plant and animal genomics. Labs/Teams: Active in the BIF group at Wageningen, collaborating with institutions like St Andrews University and the Netherlands Institute of Ecology.
Detmer Sipkema is an Associate Professor at Wageningen University & Research, affiliated with the VLAG WIMEK faculty and the Department of Molecular Ecology. His research focuses on microbial ecology, marine biology, and biotechnology, particularly in aquaculture systems and sponge symbionts. He leads projects on metabolic modeling of marine bacteria, ecological impacts of seaweed farming, and probiotics development for aquaculture. Key research interests include microbial diversity, anaerobic digestion in aquaculture waste, and applications of artificial intelligence in microbial studies. He has supervised multiple PhD candidates exploring topics like microbial symbiosis, gut microbiota dynamics, and sustainable aquaculture practices. His work integrates multi-omics approaches, environmental microbiology, and bioprospecting for novel bioactive compounds. Sipkema has published widely on sponge microbiomes, anaerobic processes, and aquaculture sustainability. His datasets include bacterial community analyses from sponges and microalgae, contributing to understanding symbiotic relationships and biotechnological applications.
Rob Willemsen is an Associate Professor in the Department of Clinical Genetics at Erasmus MC, a leading academic medical center in the Netherlands. His research is centered on the molecular and genetic basis of neurodevelopmental and inherited disorders, with a focus on fragile X syndrome and related conditions. He employs advanced models such as zebrafish and in vivo systems to investigate gene regulation, methylation dynamics, and disease mechanisms. His research interests span clinical genetics , molecular genetics , neurodevelopmental disorders , epigenetic regulation , and rare genetic diseases . Using zebrafish models, he explores gene function and pathogenic variants associated with conditions like pediatric cardiomyopathy, hereditary spastic paraplegia, and refractive errors. His work often bridges basic science with translational applications, including drug testing in preclinical models. The trends in his recent publications indicate a strong focus on gene discovery , functional genomics , and therapeutic intervention for monogenic disorders. His studies frequently involve international collaborations and multidisciplinary teams, leveraging high-throughput sequencing, transcriptomics, and animal modeling to validate candidate genes from GWAS and clinical findings. Rob Willemsen has supervised 14 research projects, indicating an active role in mentoring students and junior researchers. He has received significant attention for his work, with mentions in news outlets and citations in major journals, though specific grants or funding sources are not detailed in the text. His collaborations span multiple institutions and countries, reflecting a broad scientific network. His research is conducted within the Clinical Genetics department at Erasmus MC, where he contributes to both fundamental research and potential clinical applications. While no specific lab name is mentioned, his work involves molecular and cellular analysis, animal models, and collaboration with clinical teams to translate findings into patient care.
Prof. Juliette Legler is a Professor of Toxicology at Utrecht University's Institute for Risk Assessment Sciences (IRAS), within the Faculty of Veterinary Medicine. She leads the Division of Toxicology and previously headed the Department of Population Health Sciences (2020–2022). Her research focuses on environmental contaminants' molecular mechanisms, particularly endocrine-disrupting chemicals (EDCs), microplastics, and metabolic disorders. She coordinates major EU projects like GOLIATH (testing metabolism disruptors) and the Microplastics and Human Health Consortium (MOMENTUM), investigating fetal exposure risks. She also leads the Virtual Human Platform for Safety Assessment (VHP4Safety), advancing animal-free testing methods. Education and Career: Before Utrecht, she held roles at Brunel University London (2018) and Vrije Universiteit Amsterdam (2001–2015), where she became a Professor of Toxicology in 2013. She is a European Registered Toxicologist and former President of the Netherlands Society of Toxicology (2019–2022). Research Interests: Her work spans EDC impacts on human and wildlife health, microplastic exposure in fetal environments, and developing in vitro models to replace animal testing. Key projects include the EURION and ENKORE clusters for EDC research and the AFARA project for regulatory acceptance of non-animal assays. Publications and Awards: Over 100 publications, including landmark studies on microplastics and EDCs. Awards include the Poulsson Prize (2018), EUROTOX Lecture Award (2024), and ZonMw Pearl Award for microplastics research. She also received the VENI and VIDI grants from NWO. Grants and Projects: Coordinates €11.4M NWO projects (VHP4Safety, AFARA) and European H2020 initiatives (GOLIATH, AURORA). Her work bridges academia, industry, and policy to address environmental health challenges. Labs/Teams: Active in IRAS, leading cross-disciplinary teams in toxicology, in vitro modeling, and environmental health. Collaborates with global networks like the EURION and AURORA consortia.
Vidya Chandrasekaran is a Researcher at the Vrije Universiteit Amsterdam, affiliated with the Faculty of Science and the Department of Chemistry and Pharmaceutical Sciences. She holds an integrated Master's degree in Industrial Biotechnology from SASTRA University, India (2015), and is completing a PhD focused on iPSC-derived renal proximal tubule models for nephrotoxicity testing. Her research emphasizes developing in vitro systems for toxicity assessment using induced pluripotent stem cells (iPSCs). Key research areas include: iPSC differentiation protocols for kidney cells Nephrotoxicity testing using organoid models Transcriptomic analysis of toxic responses Animal-free chemical safety assessment She contributed to the in3 project , a multidisciplinary initiative for animal-free toxicity testing, alongside Prof. Paul Jennings. Her work has been published in journals like Toxicology in Vitro and Scientific Reports . Current projects involve advancing chronic toxicity prediction models and cadmium exposure mechanisms in renal cells. Collaborations include Harvard Medical School and Brigham and Women’s Hospital, focusing on kidney toxicology and regenerative medicine.
Dr. Joris Demmers is an Associate Professor and Head of the Marketing Department at the Faculty of Economics and Business , University of Amsterdam. His research focuses on consumer behavior, privacy in digital environments, environmental sustainability in marketing strategies, and the intersection of technology with consumer engagement. He leads academic initiatives in marketing while exploring interdisciplinary topics like corporate greenwashing detection and data governance. Key Research Themes: Consumer preferences for eco-labels and corporate social responsibility Privacy risks vs. behavioral incentives in financial and social media contexts Visual content analysis and machine learning applications in marketing Data-sharing dynamics and ethical marketing practices Recent Trends in Publications: Recent work emphasizes greenwashing detection (e.g., GreenScreen dataset), psychological drivers of financial self-disclosure, and the role of digital tools in customer journeys. Earlier studies delve into consumer data-sharing motivations and ethical privacy frameworks. Awards and Activities: No awards explicitly mentioned. Active in teaching and ancillary academic activities related to marketing strategy and digital media. Lab/Team Affiliations: No specific labs or teams listed, but collaborates across disciplines, including molecular biology studies on aging mechanisms (possibly through interdisciplinary projects).
Dr. Susanne Kooistra is a Research Professor in the Faculty of Medical Sciences at the University of Groningen, affiliated with the University Medical Center Groningen (UMCG). She leads the Senescence, Stem Cells, and Inflammation (SSI) research group, focusing on neuroinflammation, microglial biology, and epigenetic regulation in neurological disorders. Her work spans multiple sclerosis, Alzheimer’s disease, and developmental neurobiology, emphasizing the role of microglia in disease progression and repair mechanisms. Her research integrates transcriptomic and epigenetic approaches to study immune responses in the central nervous system, particularly in contexts of aging, injury, and developmental stressors. Collaborations with institutions like the UMCG and international teams have advanced insights into microglial heterogeneity, myelin repair, and the impact of environmental factors on neurodevelopmental outcomes. Dr. Kooistra’s publications highlight contributions to understanding microglial function in demyelination, stress-induced immune modulation, and epigenetic memory in neuroinflammation. Her work has been recognized through high-impact journals and international peer-reviewed contributions, with a focus on translating basic discoveries into clinical insights for neurodegenerative diseases.
Prof. Geert Smant is a Full Professor in the Laboratory of Nematology at Wageningen University & Research. His research focuses on plant-parasitic nematodes, particularly their interactions with plants, mechanisms of parasitism, and strategies for resistance in crops. He leads projects on cyst nematodes (e.g., Globodera pallida ), molecular biology of plant defenses, and genomic approaches to understand parasitic mechanisms. His work includes supervising PhD candidates and postdocs in projects like SMART UP (spatial mapping of root transcriptomes) and WORMVACS2.0 (vaccine innovations against helminths). Key contributions include genomic studies of Globodera species and elucidating effector-triggered immunity in plants. Prof. Smant has collaborated internationally, presenting at conferences like the 35th Symposium of the European Society of Nematologists and the 7th International Congress of Nematology . He oversees datasets on nematode genomics and plant responses to parasitism, available via public repositories. His team’s research spans lab-based studies, field applications, and interdisciplinary collaborations, aiming to develop durable resistance strategies against plant pathogens.
Roelof Hut is a Professor of Chronobiology at the University of Groningen, affiliated with the Faculty of Science and Engineering and the Groningen Institute for Evolutionary Life Sciences (GIELS). He leads the Hut Lab - Chronobiology, focusing on circadian rhythms, photoperiodism, and evolutionary adaptations to environmental timing cues. His roles include Chair of the International Hibernation Society and editorial board memberships for Journal of Biological Rhythms , Journal of Circadian Rhythms , and Frontiers in Ecology & Evolution . Research interests span chronobiology, evolutionary biology, and neurophysiology, with a focus on circadian entrainment mechanisms, seasonal timing in animals, and the impacts of light on physiology and behavior. He has contributed to projects like the NWA-funded BioClock initiative, investigating circadian clocks in modern society and light’s role in human health. Key collaborations include studies on light entrainment in insects, stress effects on circadian clocks, and the genomic basis of climate adaptation in species like the winter moth. His work intersects with UN Sustainable Development Goals, emphasizing health and environmental sustainability. Roelof Hut has held postdoctoral fellowships at the University of Virginia and Inserm (France), and his research outputs include over 115 peer-reviewed articles. He is actively involved in public outreach, addressing topics like daylight exposure’s cognitive effects and the societal implications of circadian misalignment.
Professor Alain de Bruin (born 1968) is a distinguished academic at Utrecht University, serving as Professor in the Department of Biomolecular Health Sciences within the Faculty of Veterinary Medicine. Since January 1, 2020, he has been Head of the Department of Biomolecular Health Sciences. His academic journey began with veterinary medicine studies at the University of Hannover in Germany, followed by a PhD from the University of Bern in Switzerland in 1999. After specializing in veterinary pathology and completing a postdoctoral position at Ohio State University, he was appointed professor of pathobiology at Utrecht University in 2005. In 2010, he founded the Netherlands Molecular Pathology Center (UU/UMCG) and became an honorary professor of molecular pathology at the University of Groningen in 2014. Professor de Bruin's research primarily focuses on cancer biology, liver pathology, tumor suppression mechanisms, and aging processes. His expertise includes in vivo modeling, cell cycle analysis, generating transgenic mouse models, pathological analysis of animal disease models, and single-cell transcriptomics. His work centers on proteins that regulate cell proliferation, particularly E2F transcription factors, which he has discovered play critical roles in inhibiting cancer cell growth. His research themes span Life Sciences, Regenerative Medicine, and the Utrecht Platform for Organoid Technology. Analysis of his recent publications reveals a consistent research trajectory centered on cell cycle regulation, particularly the atypical E2F transcription factors (E2F7 and E2F8), and their roles in cancer development, polyploidization, and liver disease. His work demonstrates how these factors influence tumor suppression, angiogenesis, and cellular responses to DNA damage. The publications span multiple disciplines including cancer biology, molecular oncology, hepatology, and regenerative medicine, with applications in both human and veterinary medicine. Professor de Bruin has held significant leadership positions, including chairing the research council (2017-2019) and coordinating the 'Regenerative Medicine, Stem Cells, and Cancer' research program (2013-2019). He serves on the editorial board of 'Frontiers in Cell and Developmental Biology' and participates in review committees for NWO-Rubicon/Veni, the research alliance UTwente/UU/UMCU, and the Comprehensive Cancer Center at Ohio State University. His laboratory work has made significant contributions to understanding how E2F transcription factors regulate cell proliferation, with implications for developing novel cancer therapy strategies. His research on polyploidization mechanisms has provided insights into liver regeneration and tumor development, while his work on senescence has implications for aging-related diseases.
Paul Jennings is a Full Professor and Chair of Molecular and Computational Toxicology at the Vrije Universiteit Amsterdam (VU), Netherlands. He holds dual appointments in the Faculty of Science (Chemistry and Pharmaceutical Sciences Department) and AIMMS. His research focuses on advancing in vitro toxicology models, particularly for renal and hepatic systems, integrating omics technologies and computational approaches to understand chemical toxicity mechanisms. Jennings has pioneered the use of induced pluripotent stem cells (iPSCs) for developing patient-specific models to study nephrotoxicity and stress response pathways such as Nrf2, p53, and HIF-1α. He has led major EU projects like EUToxRisk and OpenRiskNet, advancing animal-free testing strategies aligned with Adverse Outcome Pathways (AOPs). Education: BSc (Pharmacology, UCD Dublin), PhD (Nephrotoxicity Testing, UCD Dublin), Habilitation (Epithelial Physiology, Innsbruck Medical University). Research Interests: Development of human-relevant in vitro models, systems toxicology, mitochondrial toxicity, xenobiotic metabolism, and translational biomarkers. His work emphasizes integrating omics data (transcriptomics, proteomics) with cheminformatics and computational models to predict chemical hazards. Grants & Projects: Principal Investigator for RISKHUNT3R, CHIAZMA, VHP4SAFETY. Collaborates on EU initiatives like In3 (animal-free nanomaterial safety) and StemBANCC (stem cell-based drug toxicity). Awards: None explicitly listed, though his leadership roles (Editor-in-Chief of Toxicology in Vitro, Vice President of NVT) highlight his professional standing. Labs/Teams: Molecular and Computational Toxicology Division at VU, collaborating with international teams on projects like OpenRiskNet (e-infrastructure for risk assessment) and EUToxRisk (mechanism-based toxicity testing).
Jaap Keijer is a Full Professor and Chairholder in the Department of Human and Animal Physiology at Wageningen University & Research. His research focuses on metabolic physiology, particularly energy metabolism, mitochondrial function, and the interplay between diet, aging, and chronic metabolic diseases. He leads projects investigating nicotinamide nucleotide transhydrogenase (NNT) in energy metabolism, galactose's effects on metabolic programming, and the role of environmental factors like hypoxia in muscle physiology. He serves on the editorial board of Molecular Nutrition and Food Research and advises the German Institute of Human Nutrition. His work integrates molecular, cellular, and whole-organism approaches to understand health and disease mechanisms. Key research themes include metabolic adaptations in obesity, mitochondrial dysfunction in aging, and translational biomarker development for physical activity and metabolic health. Dr. Keijer teaches courses on molecular nutritional physiology, model organisms for lifespan research, and dissection-free human/animal physiology. His projects address clinical challenges such as sarcopenia, atrial fibrillation, and nutrient interventions for metabolic disorders. Recent studies explore dietary galactose's programming effects on intestinal metabolism and the impact of NNT deficiency on cardiac health. His lab employs advanced techniques like single-cell transcriptomics and Seahorse extracellular flux analysis to study metabolic pathways in humans and animal models. Publications emphasize mitochondrial dysfunction, metabolic biomarkers, and translational models for aging and disease. His work bridges basic research and clinical applications, aiming to improve metabolic health through dietary and lifestyle interventions. Current initiatives include developing a human gut-on-a-chip model and validating integrative biomarkers for physical activity in adolescents.
